调动美国食品药品监督管理局的获益-风险专业知识以应对当前的阿片类药物滥用流行问题。 - Suppr

Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic.

作者信息

Gottlieb Scott, Woodcock Janet

机构信息

US Food and Drug Administration, Silver Spring, Maryland.

出版信息

JAMA. 2017 Aug 1;318(5):421-422. doi: 10.1001/jama.2017.9205.

DOI:10.1001/jama.2017.9205

PMID:28687816

Abstract

摘要

相似文献

Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic.

JAMA. 2017 Aug 1;318(5):421-422. doi: 10.1001/jama.2017.9205.

Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine.

JAMA. 2017 Aug 1;318(5):423-424. doi: 10.1001/jama.2017.10046.

Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).

JAMA. 2012 Aug 1;308(5):457-8. doi: 10.1001/jama.2012.8165.

New Data on Opioid Use and Prescribing in the United States.

JAMA. 2017 Aug 1;318(5):425-426. doi: 10.1001/jama.2017.8913.

The US Opioid Crisis: Current Federal and State Legal Issues.

Anesth Analg. 2017 Nov;125(5):1675-1681. doi: 10.1213/ANE.0000000000002403.

REMS; red tape, or a remedy for opioid abuse?

J Fam Pract. 2011 Sep;60(9 Suppl):S55-62.

Pain & opioid addiction: hydrocodone update & zohydro. The paradigm for the epidemic..... continues.

W V Med J. 2014 Nov-Dec;110(6):6-10.

The opioid crisis: the needle and the damage done.

Lancet Gastroenterol Hepatol. 2017 Jun;2(6):385. doi: 10.1016/S2468-1253(17)30112-7.

The Food and Drug Administration Should Mandate Risk Evaluation and Mitigation Strategies Training for All Opioids.

Anesth Analg. 2018 Apr;126(4):1413-1417. doi: 10.1213/ANE.0000000000002888.

Addressing the Opioid Epidemic - Opportunities in the Postmarketing Setting.

N Engl J Med. 2017 Apr 20;376(16):1502-1504. doi: 10.1056/NEJMp1614972.

引用本文的文献

Feasibility of using real-world data to emulate substance use disorder clinical trials: a cross-sectional study.

BMC Med Res Methodol. 2024 Aug 28;24(1):187. doi: 10.1186/s12874-024-02307-1.

Prescription Opioid Misuse in Older Adult Surgical Patients: Epidemiology, Prevention, and Clinical Implications.

J Addict Nurs. 2022;33(4):218-232. doi: 10.1097/JAN.0000000000000488.

The Xyrem (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017.

Drugs Real World Outcomes. 2021 Mar;8(1):15-28. doi: 10.1007/s40801-020-00223-6. Epub 2021 Jan 13.

Patterns of Immediate-Release and Extended-Release Opioid Analgesic Use in the Management of Chronic Pain, 2003-2014.

JAMA Netw Open. 2018 Jun 1;1(2):e180216. doi: 10.1001/jamanetworkopen.2018.0216.

Empirical Studies Addressing the Opioid Epidemic: An Urgent Call for Research.

Subst Abuse. 2018 Aug 12;12:1178221818784294. doi: 10.1177/1178221818784294. eCollection 2018.

Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects.

Pain Res Manag. 2018 Apr 23;2018:7276021. doi: 10.1155/2018/7276021. eCollection 2018.

Regulatory Change Versus Legislation Impacting Health Care Decisions and Delivery.

P T. 2018 Jan;43(1):34-38.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献